MTOR and neoplasm: Many studies have shown that the glycolysis activity of tumor cells, mediated by circRNA, limits the glucose consumption of TILs leading to T cells failure and immune escape, and that metabolic limitation of T cell activation, inhibition of mTOR activity, reduction of glycolysis and IFN-y production, leads to tumor progression [87,88].